Neuroinflammation in the Pathogenesis of Psychiatric Disorder

  • Eric Herlambang Sutantio Sebelas Maret University, Indonesia
  • Ines Damayanti Octaviani Siloam Hospital Bekasi Timur, Indonesia
Keywords: psychiatric disorder, neuroinflammation, pathogenesis

Abstract

The mechanism of psychiatric disorders biologically has not been fully explained. The development of the pathogenesis of various diseases lately can be explained through the theory of inflammation. The theory of inflammation that may be related to the pathogenesis of psychiatric disorders is the kynurenine theory. From this kynurenine theory, the author tries to construct the mechanism of psychiatric disorders such as those that occur in cases of anxiety, depression, schizophrenia, insomnia to psychosomatic cases and epilepsy. From the various courses of psychiatric disorders, the author concludes that the mechanism of the occurrence of various psychiatric disorders is actually the same, but in the end, what distinguishes the occurrence of certain types of psychiatric disorders is the genetic factor of each individual who experiences it. It is essential to understand the mechanisms underlying psychiatric disorders from a biological perspective, as this knowledge serves as a foundation for managing such conditions, particularly through the use of psychopharmacological treatments and other adjunctive therapies.

Downloads

Download data is not yet available.

References

Ahmadi, S., Taghizadieh, M., Mehdizadehfar, E., Hasani, A., Khalili Fard, J., Feizi, H., et al. (2024). Gut microbiota in neurological diseases: Melatonin plays an important regulatory role. Biomedical Pharmacotherapy, 174, Article 116487. https://doi.org/10.1016/j.biopha.2024.116487

Anilkumar, S., & Wright-Jin, E. (2024). NF-κB as an inducible regulator of inflammation in the central nervous system. Cells, 65, 1–12.

Bigalke, J. A., Shan, Z., & Carter, J. R. (2022). Orexin, sleep, sympathetic neural activity, and cardiovascular function. Hypertension, 79(12), 2643–2655.

Brunoni, A. R., Supasitthumrong, T., Lucio, A., Lm, E., Gattaz, W. F., Benseñor, I. M., et al. (2019). Differences in the immune-inflammatory profiles of unipolar and bipolar depression. Journal of Affective Disorders, 262, 8–15.

D’Alessio, F. R., Kurzhagen, J. T., & Rabb, H. (2019). Reparative T lymphocytes in organ injury. Journal of Clinical Investigation, 129(7), 2608–2618.

Dedovic, K., Slavich, G. M., Muscatell, K. A., Irwin, M. R., & Eisenberger, N. I. (2016). Dorsal anterior cingulate cortex responses to repeated social evaluative feedback in young women with and without a history of depression. Frontiers in Behavioral Neuroscience, 10, Article MAR, 1–13.

Dimitrov, S., Benedict, C., Heutling, D., Westermann, J., Born, J., & Lange, T. (2009). Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood, 113(21), 5134–5143.

Dungey, M., Hull, K. L., Smith, A. C., Burton, J. O., Bishop, N. C., Kidney, L., et al. (2013). Inflammatory factors and exercise in chronic kidney disease. Kidney Research.

Fernandes, B. S., Inam, M. E., Enduru, N., Quevedo, J., & Zhao, Z. (2023). The kynurenine pathway in Alzheimer’s disease: A meta-analysis of central and peripheral levels. Brazilian Journal of Psychiatry, 45(3), 286–297.

Felger, J. C., & Lotrich, F. E. (2013). Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications. Neuroscience, 246, 199–229.

Feltes, P. K., Doorduin, J., Klein, H. C., Juárez-Orozco, L. E., Dierckx, R. A. J. O., Moriguchi-Jeckel, C. M., et al. (2017). Anti-inflammatory treatment for major depressive disorder: Implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. Psychiatry Research.

Forster, G. L., Novick, A. M., Scholl, J. L., & Watt, M. J. (2012). The role of the amygdala in anxiety disorders. Psychiatry Research.

Garcia-Alvarez, L., Caso, J. R., Garcia-Portilla, M. P., de la Fuente-Tomas, L., Gonzales-Blanco, L., Martinez-Saiz, P., et al. (2017). Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls. European Psychiatry, 1–10.

Ginhoux, F., Lim, S., Hoeffel, G., Low, D., & Huber, T. (2013). Origin and differentiation of microglia. Frontiers in Cellular Neuroscience, 7, Article MAR, 1–14.

Goldsmith, D. R., & Rapaport, M. H. (2020). Inflammation and negative symptoms of schizophrenia: Implications for reward processing and motivational deficits. Frontiers in Psychiatry, 11, Article February, 1–14

Gomez, E. A., Vega, B. C., & Cordero, M. D. (2017). Stress-induced NLRP3 inflammasome in human diseases. In Advances in Protein Chemistry and Structural Biology (1st ed., pp. 128–154). Academic Press.

Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015). Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α, and C-reactive protein in patients with major depressive disorder. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2015.06.001

Haapakoski, R., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2016). Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 66, 63–72. https://doi.org/10.1016/j.pnpbp.2015.11.012

Hange, D., Bengtsson, C., Sundh, V., & B̈orkelund, C. (2007). The natural history of psychosomatic symptoms and their association with psychological symptoms: Observations from the population study of women in Gothenburg. European Journal of General Practice, 13(2), 60–66.

Hughes, M. M., Connor, T. J., & Harkin, A. (2016). Stress-related immune markers in depression: Implications for treatment. Psychiatry Research, 19, 1–19.

Inam, M. E., Fernandes, B. S., Salagre, E., Grande, I., Vieta, E., Quevedo, J., et al. (2023). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A systematic review and meta-analysis of cerebrospinal fluid studies. Brazilian Journal of Psychiatry, 45(4), 343–355.

Järventausta, K., Sorri, A., Kampman, O., Björkqvist, M., Tuohimaa, K., Hämäläinen, M., et al. (2017). Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression. Acta Psychiatrica Scandinavica, 135(1), 87–92.

Jászberényi, M., Thurzó, B., Bagosi, Z., Vécsei, L., & Tanaka, M. (2024). The orexin/hypocretin system, the peptidergic regulator of vigilance, orchestrates adaptation to stress. Biomedicines, 12(2), 1–25.

Javed, A., & Fountoulakis, K. N. (2015). Advances in psychiatry. Psychiatry Research.

Kaplan, H. I., & Sadock, B. J. (2017). Kaplan and Sadock’s comprehensive textbook of psychiatry (10th ed., Vol. 1, pp. 4463–4489). Wolters Kluwer.

Klimt, F., Jacobi, C., Brähler, E., Stöbel-Richter, Y., Zenger, M., & Berth, H. (2023). Insomnia symptoms in adulthood: Prevalence and incidence over 25 years. Sleep Medicine, 109, 240–244.

Konadhode, R. R., Pelluru, D., & Shiromani, P. J. (2015). Neurons containing orexin or melanin concentrating hormone reciprocally regulate wake and sleep. Frontiers in Systems Neuroscience, 8, Article JAN, 1–9.

Kusnecov, A. W., & Anisman, H. (2014). The Wiley-Blackwell handbook of psychoneuroimmunology. Wiley-Blackwell.

Lee, H. Y., Acosta, T. J., Tanikawa, M., Sakumoto, R., Komiyama, J., Tasaki, Y., et al. (2007). The role of glucocorticoid in the regulation of prostaglandin biosynthesis in non-pregnant bovine endometrium. Journal of Endocrinology, 193(1), 127–135.

Li, B., Yang, W., Ge, T., Wang, Y., & Cui, R. (2022). Stress-induced microglial activation contributes to depression. Pharmacology Research.

Ma, K., Zhang, H., & Baloch, Z. (2016). Pathogenetic and therapeutic applications of tumor necrosis factor-α (TNF-α) in major depressive disorder: A systematic review. Psychiatry Research.

Marx, W., McGuinness, A. J., Rocks, T., Ruusunen, A., Cleminson, J., Walker, A. J., et al. (2021). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A meta-analysis of 101 studies. Molecular Psychiatry, 26(8), 4158–4178. https://doi.org/10.1038/s41380-020-00951-9

Maydych, V. (2019). The interplay between stress, inflammation, and emotional attention: Relevance for depression. Frontiers in Neuroscience, 13, Article APR, 1–8.

McCusker, R. H., Kavelaars, A., Heijnen, C. J., Dantzer, R., & Kelley, K. W. (2014). Depression, inflammation, and tryptophan metabolism. In The Wiley-Blackwell handbook of psychoneuroimmunology (pp. 448–468). Wiley-Blackwell. http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2013-23611-023&site=ehost-live&scope=site

Mehta, P., Miszta, P., Rzodkiewicz, P., Michalak, O., Krzeczyński, P., & Filipek, S. (2020). Enigmatic histamine receptor H4 for potential treatment of multiple inflammatory, autoimmune, and related diseases. Life, 10(4).

Mekori, Y. A., & Metcalfe, D. D. (1999). Mast cell-T cell interactions. Journal of Allergy and Clinical Immunology, 104(3 II), 517–523

Melmed, S., & Jameson, J. L. (2015). Anterior pituitary: Physiology of pituitary hormones. In D. L. Kasper, S. L. Hauser, J. L. Jameson, A. S. Fauci, D. L. Longo, & J. Loscalzo (Eds.), Harrison’s principles of internal medicine (19th ed., pp. 2251–2255). McGraw-Hill Education.

Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2016). Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology, 1–17. https://doi.org/10.1038/npp.2016.146

Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34. https://doi.org/10.1038/nri.2015.5

Miller, A. H., & Raison, C. L. (2017). The role of inflammation in depression: From evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22–34.

Muller, N. (2018). Inflammation in schizophrenia: Pathogenetic aspects and therapeutic considerations. Psychiatry Research, 1–10.

Muskin, P. R. (2024). What is somatic symptom disorder? American Psychiatric Association. https://www.psychiatry.org/patients-families/somatic-symptom-disorder/what-is-somatic-symptom-disorder

Noto, C., Rizzo, L. B., Mansur, R., Brietzke, E., & Maes, M. (2015). Major depression: An immune-inflammatory disorder. In N. Müller, A.-M. Myint, & M. J. Schwarz (Eds.), Immunology and psychiatry: From basic research to therapeutic interventions (pp. 147–160). Springer International Publishing AG.

Obara, I., Telezhkin, V., Alrashdi, I., & Chazot, P. L. (2020). Histamine, histamine receptors, and neuropathic pain relief. British Journal of Pharmacology, 177(3), 580–599.

Poligone, B., & Baldwin, A. S. (2001). Positive and negative regulation of NF-κB by COX-2. Roles of different prostaglandins. Journal of Biological Chemistry, 276(42), 38658–38664. https://doi.org/10.1074/jbc.M106599200

Reina-Campos, M., Scharping, N. E., & Goldrath, A. W. (2021). CD8+ T cell metabolism in infection and cancer. Nature Reviews Immunology, 21(11), 718–738.

Roe, K. (2021). An inflammation classification system using cytokine parameters. Scandinavian Journal of Immunology, 93(2), 6–10.

Roesler, R., Parent, M. B., LaLumiere, R. T., & McIntyre, C. K. (2021). Amygdala-hippocampal interactions in synaptic plasticity and memory formation. Neurobiology of Learning and Memory, 184, Article 107490. https://doi.org/10.1016/j.nlm.2021.107490

Romeo, B., Brunet-Lecomte, M., & Martelli, C. (2018). Kinetics of cytokine levels during antipsychotic treatment in schizophrenia: A meta-analysis. Psychiatry Research.

Sharma, R., Sahota, P., & Thakkar, M. M. (2018). Melatonin promotes sleep in mice by inhibiting orexin neurons in the perifornical lateral hypothalamus. Journal of Pineal Research, 65(2), 1–10.

Simons, F. E. R., & Simons, K. J. (2011). Histamine and H1-antihistamines: Celebrating a century of progress. Journal of Allergy and Clinical Immunology, 128(6), 1139–1150.e4. https://doi.org/10.1016/j.jaci.2011.09.005

Singh, M. K. (2015). The neuroscience of depression: Implications for assessment and intervention. NIH Public Access, 650, 60–73.

Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin, 140(3), 774–815.

Smith-Garvin, J. E., Koretszky, G. A., & Jordan, M. S. (2009). T cell activation. Annual Review of Immunology, 27(1), 591–619.

Smith, J. A., Ji, Y., Lorsung, R., Breault, M. S., Koenig, J., Cramer, N., et al. (2023). Parabrachial nucleus activity in nociception and pain in awake mice. Journal of Neuroscience, 43(31), 5656–5677.

Stahl, S. M. (2021). Stahl′s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed., pp. 77–578). Mens Sana Monographs.

Swardfager, W., Rosenblat, J. D., Benlamri, M., & McIntyre, R. S. (2016). Mapping inflammation onto mood; Inflammatory mediators of anhedonia. Neuroscience & Biobehavioral Reviews.

Tami, F., Ashutosh, T., & Anilkumar, P. (2020). 乳鼠心肌提取 HHS public access. Physiology & Behavior, 176(1), 139–148.

Thangam, E. B., Jemima, E. A., Singh, H., Baig, M. S., Khan, M., Mathias, C. B., et al. (2018). The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Frontiers in Immunology, 9, Article AUG, 1–9.

Tolbert, M. K. (2021). Gastroprotective therapy. Veterinary Clinics of North America - Small Animal Practice, 51(1), 33–41. https://doi.org/10.1016/j.cvsm.2020.09.001

Upthegrove, R., & Khandaker, G. M. (2018). Cytokines, oxidative stress, and cellular markers of inflammation in schizophrenia. Psychiatry Research

Van de Veerdonk, M. M. G. H., Bouwens van der Vlis, T. A. M., Ackermans, L., Schruers, K. R. J., Temel, Y., & Leentjens, A. F. G. (2023). The role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder. Deep Brain Stimulation, 3(July), 1–7.

Wang, Y., Li, R., Zhang, M., Zhang, Z., Qu, W., & Huang, Z. (2015). The neurobiological mechanisms and treatments of REM sleep disturbances in depression. Neuroscience Research, 543–553.

Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic kidney disease. Lancet, 389(10075), 1238–1252.

Wohleb, E. S. (2019). Autonomic control of immune function. Oxford Research Encyclopedia of Neuroscience.

Won, E., & Kim, Y. (2016). Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression. Psychiatry Research, 665–673.

World Health Organization. (2023). Depressive disorder (depression). World Health Organization. https://www.who.int/news-room/fact-sheets/detail/depression

World Health Organization. (2024). Bipolar disorder. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/bipolar-disorder

Yamada, Y., Matsumoto, M., Iijima, K., & Sumiyoshi, T. (2019). Specificity and continuity of schizophrenia and bipolar disorder: Relation to biomarkers. Current Pharmaceutical Design, 26(2), 191–200.

Yrondi, A., Sporer, M., Péran, P., Schmitt, L., Arbus, C., & Sauvaget, A. (2017). Electroconvulsive therapy, depression, the immune system, and inflammation: A systematic review. Brain Stimulation. https://doi.org/10.1016/j.brs.2017.10.013

Yu, X., Franks, N. P., & Wisden, W. (2018). Sleep and sedative states induced by targeting the histamine and noradrenergic systems. Frontiers in Neural Circuits, 12, Article January, 1–17.

Zunszain, P. A., Hepgul, N., & Pariante, C. M. (2012). Inflammation and depression. Brain Imaging and Behavioral Neuroscience, 289–320. https://doi.org/10.1007/7854_2011_176

Published
2025-05-05
How to Cite
Sutantio, E. H., & Octaviani, I. D. (2025). Neuroinflammation in the Pathogenesis of Psychiatric Disorder. Bulletin of Counseling and Psychotherapy, 7(2). https://doi.org/10.51214/002025071341000